Lexaria Bioscience Corp. Common Stock
$3.24
-$0.05 (-1.52%)
$3.15Day Range$3.52
Key Statistics
Market Cap
$6.93M
Shares Outstanding
2.1M
Primary Exchange
XNAS
Currency
USD
Type
CS
IPO Date
Sep 8, 2006
Round Lot
100
Locale
US
Trading Data
Day Open
$3.25
Day High
$3.52
Day Low
$3.15
Volume
76.3K
VWAP
$3.33
Prev Close
$3.29
Transactions
--
Acc. Volume
--
About Lexaria Bioscience Corp. Common Stock
Lexaria Bioscience Corp is a biotechnology company focused on enhancing the bioavailability of active pharmaceutical ingredients using its patented DehydraTECH drug delivery technology. DehydraTECH improves absorption, effectiveness, and tolerability and can be applied to APIs such as GLP-1 and GIP drugs, vitamins, pain medications, hormones, antivirals, nicotine and cannabinoids across therapeutic areas including diabetes, weight loss, epilepsy, hypertension, and heart disease. It can be used in formats such as tablets, capsules, oral suspensions, foods, beverages, and pouches, and supports pharmaceuticals, nutraceuticals, over-the-counter products, and consumer packaged goods. The Company operates one segment: IP licensing, generating revenue from licensing its DehydraTECH technology.
PHARMACEUTICAL PREPARATIONSSIC 28347 employees100 - 740 MCCURDY ROAD, KELOWNA, A1, V1X 2P7250-765-6424IPO Sep 8, 2006US / STOCKSActiveWebsite
Identifiers
- CIK
- 0001348362
- Composite FIGI
- BBG000JQHT18
- Share Class FIGI
- BBG001SBJ1Q1
- Ticker Root
- LEXX
- SIC Code
- 2834
About Lexaria Bioscience Corp. Common Stock (LEXX) Stock
Lexaria Bioscience Corp. Common Stock (LEXX) closed the 2026-09-18 session at $3.24, down 1.52% versus the previous close (-0.05). The stock opened at $3.25 and traded between $3.15 and $3.52 during that session. Session trading volume was 76K shares. The volume-weighted average price (VWAP) is $3.33.
Lexaria Bioscience Corp is a biotechnology company focused on enhancing the bioavailability of active pharmaceutical ingredients using its patented DehydraTECH drug delivery technology. DehydraTECH improves absorption, effectiveness, and tolerability and can be applied to APIs such as GLP-1 and GIP drugs, vitamins, pain medications, hormones, antivirals, nicotine and cannabinoids across therapeutic areas including diabetes, weight loss, epilepsy, hypertension, and heart disease. It can be used in formats such as tablets, capsules, oral suspensions, foods, beverages, and pouches, and supports pharmaceuticals, nutraceuticals, over-the-counter products, and consumer packaged goods. The Company operates one segment: IP licensing, generating revenue from licensing its DehydraTECH technology.
Lexaria Bioscience Corp. Common Stock has a market capitalization of $6.9 million. The company operates in the PHARMACEUTICAL PREPARATIONS industry classification. LEXX is listed on the XNAS exchange. The company employs approximately 7 people. Lexaria Bioscience Corp. Common Stock is headquartered in KELOWNA, A1. The recorded listing date is 2006-09-08.
On this page you can find market LEXX stock price data, interactive price charts with multiple timeframes (1 day to max history), company financials including income statements, balance sheets, and cash flow statements, technical indicators (SMA 50, SMA 200, EMA 20, MACD, RSI), latest news and sentiment analysis, dividend history, stock splits, short interest data, float information, and related stocks.
Explore more: View today's market movers, use the stock screener, or browse all sectors. See more stocks in the PHARMACEUTICAL PREPARATIONS sector.